Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 9/20 | 0.48 |
| ▸ | NR3C1 | P04150 | 6/20 | 0.48 |
| ▸ | AR | P10275 | 5/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7985006 | 0.94 | PGR (0.50) | PGRNR3C1ARHSD17B10ALDH1A1 | |
| SCHEMBL7988315 | 0.91 | PARP1 (0.42) | PGRNR3C1ARHSD17B10ALDH1A1 | |
| SCHEMBL5670843 | 0.84 | PARP1 (0.45) | NR3C1HSD17B10ALDH1A1PARP1BRD4 | |
| SCHEMBL5670690 | 0.82 | PARP1 (0.55) | HSD17B10ALDH1A1PARP1BRD4USP2 | |
| SCHEMBL5672408 | 0.81 | ALDH1A1 (0.40) | NR3C1HSD17B10ALDH1A1PARP1BRD4 | |
| SCHEMBL5672792 | 0.81 | BRD4 (0.41) | PGRNR3C1ARHSD17B10ALDH1A1 | |
| SCHEMBL5672871 | 0.80 | ALDH1A1 (0.41) | PGRHSD17B10ALDH1A1PARP1BRD4 | |
| SCHEMBL5670684 | 0.77 | HSD17B10 (0.53) | PGRHSD17B10ALDH1A1PARP1BRD4 | |
| SCHEMBL7985016 | 0.75 | PGR (0.45) | PGRNR3C1HSD17B10ALDH1A1PARP1 | |
| SCHEMBL7982283 | 0.73 | EGFR (0.54) | HSD17B10ALDH1A1USP2MAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6191127-B1 | ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, CARDIOVASCULAR DISORDERS, NERVOUS SYSTEM DISORDERS | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-02-20 | — | — | US | disclosed |